Isopropyl Alcohol

Isopropyl Alcohol

SCHEMBL6661541

CC(C)O.CCN(CC)CC.O=C(Cl)C(=O)Cl

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.36
CA9 Q16790 4/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 2/20 0.36
CHRM2 P08172 2/20 0.35
CHRM4 P08173 2/20 0.35
CHRM5 P08912 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 2/20 0.35
TSHR P16473 4/20 0.32
ALDH1A1 P00352 4/20 0.32
LMNA P02545 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360690 0.89 TSHR (0.38) CA12CA9CA1CA2CHRM2
Isopropyl Alcohol SCHEMBL3893557 0.83 ALDH1A1 (0.46) CHRM2CHRM4CHRM5CHRM1CHRM3
Acetic Acid SCHEMBL9796859 0.81 CHRM2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
Isopropyl Alcohol SCHEMBL3202296 0.80 ALDH1A1 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3
Isopropyl Alcohol SCHEMBL28231979 0.80 ALDH1A1 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
Isopropyl Alcohol SCHEMBL18984957 0.80 ALDH1A1 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8701819 0.80 TSHR (0.40) CA12CA9CA1CA2CHRM2
Acetic Acid SCHEMBL5903857 0.79 CHRM2 (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
Chloroform SCHEMBL27284102 0.78 TSHR (0.35) CA12CA9CA1CHRM2CHRM4
SCHEMBL3640654 0.77 CHRM2 (0.42) CA12CA9CA1CA2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016569-A1 PROCESS FOR THE REDUCTION OF SULPHOXIDES TO SULPHIDES EISAI CO., LTD. (JP) 2004-02-26 WO disclosed